Identification of avarol derivatives as potential antipsoriatic drugs using an in vitro model for keratinocyte growth and differentiation
- 1 November 2006
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 79 (25), 2395-2404
- https://doi.org/10.1016/j.lfs.2006.08.003
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Potential Antipsoriatic Avarol Derivatives as Antioxidants and Inhibitors of PGE2 Generation and Proliferation in the HaCaT Cell LineJournal of Natural Products, 2004
- Emerging therapeutic targets in psoriasisCurrent Opinion in Pharmacology, 2004
- Immunomodulatory drugs for psoriasisBMJ, 2003
- Novel Therapies for PsoriasisAmerican Journal of Clinical Dermatology, 2002
- The Expression of the Gene Coding for the Antibacterial Peptide LL-37 Is Induced in Human Keratinocytes during Inflammatory DisordersJournal of Biological Chemistry, 1997
- Levels of Skin-Derived Antileukoproteinase (SKALP)/Elafin in Serum Correlate with Disease Activity During Treatment of Severe Psoriasis with Cyclosporin AJournal of Investigative Dermatology, 1995
- Avarol and avarone, two new anti-inflammatory agents of marine originEuropean Journal of Pharmacology, 1994
- NAP-1/IL-8 Immunoreactivity in Normal and Psoriatic SkinJournal of Investigative Dermatology, 1991
- Biological Activities of Avarol Derivatives, 1. Amino DerivativesJournal of Natural Products, 1990
- Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.The Journal of cell biology, 1988